Sonia Suavet-Boyer

Antibes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.

Journal: Clinical kidney journal

Published: November 16, 2024

Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188].

Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188].

Journal: Kidney international reports

Published: July 31, 2024

Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy.

Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: November 04, 2022

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy.

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy.

Journal: Frontiers in immunology

Published: January 21, 2022

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy.

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy.

Journal: Frontiers in immunology

Published: July 09, 2021

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy.

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy.

Journal: Kidney international reports

Published: November 18, 2020

Proteinuria as a Biomarker for COVID-19 Severity.

Proteinuria as a Biomarker for COVID-19 Severity.

Journal: Frontiers in physiology

Published: September 29, 2020

Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study.

Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study.

Journal: Frontiers in medicine

Published: September 21, 2020

Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients.

Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients.

Journal: Frontiers in medicine

Published: September 08, 2020

Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses.

Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses.

Journal: Frontiers in immunology

Published: June 22, 2020

Complement Pathways in Membranous Nephropathy: Complex and Multifactorial.

Complement Pathways in Membranous Nephropathy: Complex and Multifactorial.

Journal: Kidney international reports

Published: May 15, 2020

Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial.

Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial.

Journal: Frontiers in medicine

Published: February 20, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026